↵a Centers for Disease Control and Prevention. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children. Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(9):258–261.
↵b Repeat PPSV23 doses should be 5 y after the first dose.
↵c Particularly cyanotic congenital heart disease and cardiac failure.
↵d Including asthma, if treated with prolonged high-dose oral corticosteroids.
↵e Includes B- (humoral) or T-lymphocyte deficiency; complement deficiencies, particularly C1, C2, C3, and C4 deficiency; and phagocytic disorders (excluding chronic granulomatous disease).